Funding search · Alzheimer'S Disease Research Foundation · grants
Alzheimer'S Disease Research Foundation: all 448 grants
Largest first · $100.1M across 2022–2025 · back to the overview
- $201,250
Washington University in St Louis · St Louis, MO · 2025
Deciphering and restoring computational set-points in alzheimer's disease through sleep-enhanced network homeostasis
- $201,250
Washington University in St Louis · St Louis, MO · 2025
The jeffrey l. Morby prize
- $201,250
Washington University in St Louis · St Louis, MO · 2025
Specificity of t cell responses in autosomal dominant alzheimer disease (adad)
- $201,250
Washington University in St Louis · St Louis, MO · 2025
Antiviral cytokine signaling promotes neurodegeneration in alzheimer's disease
- $201,250
Washington University in St Louis · St Louis, MO · 2025
Targeting reactive astrocytes ampk signaling to suppress inflammation in alzheimer's disease
- $201,250
Washington University in St Louis · St Louis, MO · 2025
Development of small molecule inhibitors of cholesterol 25-hydroxylase
- $201,250
Washington University in St Louis · St Louis, MO · 2025
Sleep reinforces homeostatic set-points in neural activity and mitigates neurodegenerative disease
- $201,250
Weill Medical College of Cornell University · New York, NY · 2025
A three-dimensional tissue model linking tau tangles, ab and microglial cd33- isoform state to gene- and isoform-expression dysregulation
- $201,250
Brigham and Women'S Hospital · Boston, MA · 2024
Role of checkpoint molecules tim-3 and lag-3 in microglial function in alzheimer's disease
- $201,250
Carnegie Mellon University · Pittsburgh, PA · 2024
Interpreting alzheimer's disease-associated genetic variation at enhancer regions
- $201,250
Dana-Farber Cancer Institute · Boston, MA · 2024
Pre-clinical testing of cdk4/6 inhibitors as a therapeutic strategy in alzheimer's disease using ad tauopathy mouse model
- $201,250
Gladstone Institutes · San Francisco, CA · 2024
Understanding how human brain vascular cells mediate genetic risk for alzheimer's disease
- $201,250
Icahn School of Medicine at Mount Sinai · New York, NY · 2024
Investigating lysosomal mechanisms of risk and resilience in alzheimer's disease
- $201,250
Icahn School of Medicine at Mount Sinai · New York, NY · 2024
Role of psychosocial stress in alzheimer's disease
- $201,250
Icahn School of Medicine at Mount Sinai · New York, NY · 2024
Investigating the association between clonal hematopoiesis and alzheimer's disease
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Role of cd8+ t cell-glial interactions in mediating alzheimer's disease pathogenesis
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Validation and characterization of compounds modulating neuroinflammation and amyloid beta uptake in microglial cells
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Characterizing gut bacteriome-mycobiome synergy in correlation to amylin-ab antimicrobial synergy in alzheimer's disease (ad) in ad mouse models
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Exploring novel drug candidates for alzheimer's disease through integrative pathway analysis and validation in 3d cellular models
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Role of rin3 and bin1 interaction in the neurons for alzheimer's disease development
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Growth, characterization, and distribution of a neurodegenerative disease-focused fibroblast/ips cell bank to support molecular models of patient-specific variation with validation in matched donated brain tissues
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Characterization of cns-penetrant hdac 11 selective inhibitors in alzheimer's disease models
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Tau and b-amyloid are innate immune antimicrobial peptides in the brain
- $201,250
Massachusetts General Hospital · Boston, MA · 2024
Role of stabilization of mams and mam-associated palmitoylated app (mam-palapp) in alzheimer's disease
- $201,250
Mayo Clinic Jacksonville · Jacksonville, FL · 2024
Evaluating the contribution of tdp-43 dysfunction and cryptic mis-splicing to ad pathogenesis
- $201,250
Mayo Clinic Jacksonville · Jacksonville, FL · 2024
Restore meningeal lymphatic drainage to alleviate white matter damage and cerebral amyloid angiopathy in a model of alzheimer's disease
- $201,250
New York University School of Medicine · New York, NY · 2024
Midlife autoantibody profiles and the risk of late onset alzheimer's disease in women
- $201,250
President and Fellows of Harvard College · Cambridge, MA · 2024
Harvard medical school-meningeal tregs in individuals with vs without alzheimer's disease
- $201,250
President and Fellows of Harvard College · Cambridge, MA · 2024
Harvard medical school-dissecting the modulatory roles of il-17rd in alzheimer's disease
- $201,250
President and Fellows of Harvard College · Cambridge, MA · 2024
Harvard medical school-defining a role for the ms4a genes in alzheimer's disease
- $201,250
Stanford University · Redwood City, CA · 2024
Multiomics characterization of tau pathology onset and its relationship with amyloid in the human hippocampus
- $201,250
The Regents of the University of California San Francisco · San Francisco, CA · 2024
Role of the circulating exerkine gpld1 in ameliorating alzheimer's disease pathology
- $201,250
The Regents of the University of California San Francisco · San Francisco, CA · 2024
Probing the molecular underpinnings of g protein-coupled receptor adgrg1 mediated protective microglial responses to alzheimer's disease
- $201,250
The Salk Institute for Biological Studies · La Jolla, CA · 2024
The role of astrocyte-secreted lgfbp2 in the progression of alzheimer's disease
- $201,250
The Salk Institute for Biological Studies · La Jolla, CA · 2024
To elucidate the role of memory t cells as a determinant of age-related inflammation in alzheimer's disease
- $201,250
The University of Texas Health Science Center at San Antonio · San Antonio, TX · 2024
Identification and validation of plasma-based lipid biomarkers for early alzheimer's disease in the unique, primarily hispanic, south texas population
- $201,250
Univeristy of California Los Angeles · Los Angeles, CA · 2024
Novel ai decodes aging neurons
- $201,250
University of California Irvine · Irvine, CA · 2024
Bioinformatics platform for modeling alzheimer's progression (map-ad platform)
- $201,250
University of California San Diego · La Jolla, CA · 2024
Dysregulation of signaling on post synaptic density scaffolds in alzheimer's disease
- $201,250
University of Rhode Island · Kingston, RI · 2024
Effect of apoe genotype in a novel rat model of cerebral amyloid angiopathy - year 2/2
- $201,250
University of Virginia · Charlottesville, VA · 2024
Elucidating the role of clec7a in tau-mediated neurodegenerative disease
- $201,250
University of Virginia · Charlottesville, VA · 2024
Impact of dna damage-mediated sting activation on myelin function in an alzheimer's disease animal model
- $201,250
University of Washington · Seattle, WA · 2024
Elucidating the therapeutic potential of the endolysosome pathway for alzheimer's disease
- $201,250
Wake Forest University Health Sciences · Winstonsalem, NC · 2024
Investigating the role of tau protein in neuronal senescence
- $201,250
Washington University in St Louis · St Louis, MO · 2024
Targeting reactive astrocytes ampk signaling to suppress inflammation in alzheimer's disease
- $201,250
Washington University in St Louis · St Louis, MO · 2024
Specificity of t cell responses in autosomal dominant alzheimer disease (adad)
- $201,250
Washington University in St Louis · St Louis, MO · 2024
Identifying age-related proteomic changes that predict future onset of amyloid-beta aggregation in late onset alzheimer's disease
- $201,250
Washington University in St Louis · St Louis, MO · 2024
Contribution of skull bone marrow-derived cells to alzheimer's disease
- $201,250
Washington University in St Louis · St Louis, MO · 2024
Development of small molecule inhibitors of cholesterol 25-hydroxylase
- $201,250
Washington University in St Louis · St Louis, MO · 2024
2024 morby prize
- $201,250
Washington University in St Louis · St Louis, MO · 2024
Antiviral t cell infiltration to the meninges and brain influences neurodegeneration in alzheimer's disease
- $201,250
Weill Medical College of Cornell University · New York, NY · 2024
Identification and development of cd33 inhibitors and pre-rna splicing modulators
- $201,250
Weill Medical College of Cornell University · New York, NY · 2024
Tau-induced postsynaptic dysfunction in tauopathy models
- $201,250
Brigham and Women'S Hospital · Boston, MA · 2023
Neuroimmune connectome perturbations in alzheimer's disease
- $201,250
Brigham and Women'S Hospital · Boston, MA · 2023
Targeting neuroinflammation with nasal administration of anti-cd3 monoclonal antibody to treat alzheimer's disease
- $201,250
Brigham and Women'S Hospital · Boston, MA · 2023
Role of checkpoint molecules tim-3 and lag-3 in microglial function in alzheimer's disease
- $201,250
Brigham and Women'S Hospital · Boston, MA · 2023
Targeting the microbiome and innate immunity in alzheimer's disease
- $201,250
Columbia University · New York, NY · 2023
Noncoding translation feedback loop in alzheimer's disease
- $201,250
Emory University · Atlanta, GA · 2023
Mitochondrial alzheimer's risk factors control apoe expression and secretion
- $201,250
Icahn Scool of Medicine at Mount Sinai · New York, NY · 2023
Investigating lysosomal mechanisms of risk and resilience in alzheimer's disease
- $201,250
Icahn Scool of Medicine at Mount Sinai · New York, NY · 2023
Investigating mef2c transcription factor as therapeutic target to reprogram pathological microglial states in alzheimer's disease
- $201,250
Johns Hopkins University · Baltimore, MD · 2023
Human brain cd33 ligand, rptps3l, limits microglial phagocytosis and contributes to alzheimer's disease progression
- $201,250
Massachusetts General Hospital · Boston, MA · 2023
Role of rin3 and bin1 interaction in the neurons for alzheimer's disease development
- $201,250
Massachusetts General Hospital · Boston, MA · 2023
Growth, characterization, and distribution of a neurodegenerative disease-focused fibroblast/ips cell bank to support molecular models of patient-specific variation with validation in matched donated brain tissues
- $201,250
Massachusetts General Hospital · Boston, MA · 2023
Characterization of cns-penetrant hdac11-selective inhibitors in alzheimer's disease models
- $201,250
Massachusetts General Hospital · Boston, MA · 2023
Validation and characterization of compounds modulating neuroinflammation and amyloid beta uptake in microglial cells
- $201,250
Massachusetts General Hospital · Boston, MA · 2023
Role of cd8+ t cell-glial interactions in mediating alzheimer's disease pathogenesis
- $201,250
Massachusetts General Hospital · Boston, MA · 2023
Role of stabilization of mams and mam-associated palmitoylated app (mam-palapp) in alzheimer's disease
- $201,250
Massachusetts General Hospital · Boston, MA · 2023
Characterizing gut bacteriome-mycobiome synergy in correlation to amylin-a antimicrobial synergy in alzheimer's disease (ad) in ad mouse models
- $201,250
Mayo Clinic Jacksonville · Jacksonville, FL · 2023
Elucidating the protective effects of apoe2 in the presence of apoe4 gene allele in animal models
- $201,250
Mayo Clinic Jacksonville · Jacksonville, FL · 2023
Restore meningeal lymphatic drainage to alleviate white matter damage and cerebral amyloid angiopathy in a model of alzheimer's disease
- $201,250
Mayo Clinic Jacksonville · Jacksonville, FL · 2023
Abca7 loss of function in aging and alzheimer's disease
- $201,250
Mayo Clinic Jacksonville · Jacksonville, FL · 2023
Evaluating tmem106b accumulation in ad
- $201,250
Stanford University · Redwood City, CA · 2023
Multiomics characterization of tau pathology onset and its relationship with amyloid in the human hippocampus
- $201,250
The Regents of the University of Califormia San Francisco · San Francisco, CA · 2023
Neuronal mechanisms driving synapse loss in alzheimer's disease
- $201,250
The Salk Institute for Biologial Studies · La Jolla, CA · 2023
To elucidate the role of memory t cells as a determinant of age-related inflammation in alzheimer's disease
- $201,250
Tufts University · Boston, MA · 2023
Multidisciplinary phenotyping of a novel humanized load mouse model
- $201,250
University of Michigan · Ann Arbor, MI · 2023
Morphological, electrophysiological, and transcriptional characterization of single neurons from resilient and susceptible models of human ad
- $201,250
University of Rhode Island · Kingston, RI · 2023
Effect of apoe genotype in a novel rat model of cerebral amyloid angiopathy
- $201,250
University of Southern California · Los Angeles, CA · 2023
Prenatal inflammation effects on blood brain barrier function and ad-related pathologies across the lifespan
- $201,250
University of Texas Health Science Center at San Antonio · San Antonio, TX · 2023
Identification and validation of plasma-based lipid biomarkers for early alzheimer's disease in the unique, primarily hispanic, south texas population
- $201,250
University of Virginia · Charlottesville, VA · 2023
Elucidating the role of clec7a in tau-mediated neurodegenerative disease
- $201,250
University of Virginia · Charlottesville, VA · 2023
Exploring the therapeutic potential of clusterin in a preclinical model of alzheimer's disease
- $201,250
Washington University · St Louis, MO · 2023
Contribution of skull bone marrow-derived cells to alzheimer's disease
- $201,250
Washington University · St Louis, MO · 2023
Dissecting alzheimer's disease phenotypes in directly reprogrammed patient-derived neurons
- $201,250
Weill Cornell · New York, NY · 2023
Tau-induced postsynaptic dysfunction in tauopathy models
- $201,250
Weill Cornell · New York, NY · 2023
Identification and development of cd33 inhibitors and pre-rna splicing modulators
- $201,250
Brigham and Women'S · Boston, MA · 2022
Targeting the microbiome and innate immunity in alzheimers disease
- $201,250
Brigham and Women'S · Boston, MA · 2022
Neuroimmune connectome perturbations in alzheimers disease
- $201,250
Harvard Medical School · Boston, MA · 2022
Dissecting the modulatory roles of interleukin-17 receptor d in alzheimer's disease
- $201,250
Johns Hopkins · Baltimore, MD · 2022
Human brain cd33 ligand, rptps3l, limits microglial phagocytosis and contributes to alzheimers disease progression
- $201,250
Mayo Jacksonville · Jacksonville, FL · 2022
Abca7 loss of function in aging and alzheimers disease
- $201,250
Mayo Jacksonville · Jacksonville, FL · 2022
Evaluating tmem106b accumulation in ad
- $201,250
University of California San Francisco · San Francisco, CA · 2022
Role of the circulating exerkine gpld1 in ameliorating alzheimers disease pathology
- $201,250
University of California San Francisco · San Francisco, CA · 2022
Understanding how human brain vascular cells mediate genetic risk for alzheimer's disease
- $201,250
University of Southern California · Los Angeles, CA · 2022
Prenatal inflammation effects on blood brain barrier function and ad-related pathologies across the lifespan
- $201,250
University of Virginia · Charlottesville, VA · 2022
Exploring the therapeutic potential of clusterin in a preclinical model of alzheimers disease
- $201,248
Washington University · St Louis, MO · 2023
Antiviral t cells infiltration to the meninges and brain influences neurodegeneration in alzheimer's disease
- $201,235
Icahn School of Medicine at Mount Sinai · New York, NY · 2025
Restoring brain collection in new york city through the mount sinai neuropathology brain bank
- $201,235
Beth Israel Deadoness Medical Center · Boston, MA · 2024
Integrating single-cell genomics for pathways to protection and resilience against alzheimer's disease